Blue Smoke

A new kind of pharmaceutical company delivering asset centricity at scale.

About Us

We represent a new kind of pharmaceutical company with a deconstructed R&D environment that prioritizes data driven decision making led by subject matter experts. Centessa companies are advancing a portfolio of high conviction programs with strong biological validation.

Our asset-centric model offers a unique R&D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.

10 Companies.
300 Active Patents.
Centessa Pharmaceuticals

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser